Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fulda

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Oncogene|May 13, 2008
Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cellsM A Westhoff, S Zhou, M G Bachem, et al.
Medicine and Science in Sports and Exercise|April 25, 2025
Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank CohortEvelynne S Fulda, Laura Portas, Charlie Harper, et al.
European Journal of Neurology|August 21, 2012
Hypersomnia due to bilateral thalamic lesions: unexpected response to ModafinilI Zavalko, C L Bassetti, A Cianfoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspasesC Beltinger, S Fulda, T Kammertoens, et al.
Oncogene|August 9, 2011
Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cellsC Jennewein, S Karl, B Baumann, et al.
Cell Death and Differentiation|February 4, 2014
Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κBA Tchoghandjian, C Jennewein, I Eckhardt, et al.
Oncogene|April 21, 2001
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosisS Fulda, E Meyer, C Friesen, et al.
Cell Death & Disease|June 22, 2012
NOXA as critical mediator for drug combinations in polychemotherapyH Ehrhardt, I Höfig, F Wachter, et al.
Current Medicinal Chemistry|June 12, 2012
Survivin as a prognostic/predictive marker and molecular target in cancer therapyF Rödel, T Sprenger, B Kaina, et al.
Blood|October 24, 1997
Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)M Los, I Herr, C Friesen, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Oncogene|May 13, 2008
Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cellsM A Westhoff, S Zhou, M G Bachem, et al.
Medicine and Science in Sports and Exercise|April 25, 2025
Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank CohortEvelynne S Fulda, Laura Portas, Charlie Harper, et al.
European Journal of Neurology|August 21, 2012
Hypersomnia due to bilateral thalamic lesions: unexpected response to ModafinilI Zavalko, C L Bassetti, A Cianfoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspasesC Beltinger, S Fulda, T Kammertoens, et al.
Oncogene|August 9, 2011
Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cellsC Jennewein, S Karl, B Baumann, et al.
Cell Death and Differentiation|February 4, 2014
Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κBA Tchoghandjian, C Jennewein, I Eckhardt, et al.
Oncogene|April 21, 2001
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosisS Fulda, E Meyer, C Friesen, et al.
Cell Death & Disease|June 22, 2012
NOXA as critical mediator for drug combinations in polychemotherapyH Ehrhardt, I Höfig, F Wachter, et al.
Current Medicinal Chemistry|June 12, 2012
Survivin as a prognostic/predictive marker and molecular target in cancer therapyF Rödel, T Sprenger, B Kaina, et al.
Blood|October 24, 1997
Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)M Los, I Herr, C Friesen, et al.
Pageof 16